Risk Intelligence
Delayed JJM fund release
View Risks →Electrosteel Castings reported a weak Q3 FY26 with consolidated total income of ₹1,526 crore and EBITDA of ₹88 crore (margin 5.8%), impacted by a 31% YoY drop in DI pipe sales volume to 1.34 lakh tonnes.
Financial stats pending filing verification
Electrosteel Castings reported a weak Q3 FY26 with consolidated total income of ₹1,526 crore and EBITDA of ₹88 crore (margin 5.8%), impacted by a 31% YoY drop in DI pipe sales volume to 1.34 lakh tonnes. Domestic demand remained subdued due to a government spending freeze under Jal Jeevan Mission (JJM), though export volumes grew 11% QoQ. Management expects a gradual recovery from April 2026 as pending JJM funds (₹17,000 crore central share) are released. The company is diversifying into high-tech valves via an Italian acquisition. Key risk: sustained demand weakness if fund releases are further delayed, prolonging the current trough.
इलेक्ट्रोस्टील कास्टिंग्स की तीसरी तिमाही (अक्टूबर-दिसंबर 2025) कमजोर रही। कंपनी की कुल आय ₹1,526 करोड़ और EBITDA ₹88 करोड़ (5.8% मार्जिन) रही। इसकी मुख्य वजह डीआई पाइप की बिक्री में 31% की गिरावट (1.34 लाख टन) है। सरकार ने जल जीवन मिशन (JJM) के तहत खर्च रोक दिया, जिससे देश में मांग कम हुई। हालांकि, निर्यात पिछली तिमाही से 11% बढ़ा। कंपनी को उम्मीद है कि अप्रैल 2026 से सुधार शुरू होगा, जब JJM के ₹17,000 करोड़ के बकाया फंड जारी होंगे। साथ ही, कंपनी इटली से हाई-टेक वाल्व खरीदकर नए कारोबार में उतर रही है। खतरा: अगर फंड जारी होने में और देरी हुई, तो मांग कमजोर बनी रहेगी।
Delayed JJM fund release
View Risks →Full transcript text is available on this route.
Read Transcript →Sales volume declined sharply due to domestic demand slowdown from government spending delays.
Export volumes increased quarter-on-quarter, partially offsetting domestic weakness.
Electrosteel holds around 20% of the domestic DI pipe market, similar to peers.
Net debt reduced significantly from previous quarter due to lower working capital requirements.
Management expects Q4 sales volume to be in line with Q3, with no immediate uptick.
The ₹17,000 crore central share for JJM is pending cabinet approval; further delays could prolong demand weakness.
View Risks →